Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven N Hart

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2021
Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk ScoreChi Gao, Eric C Polley, Steven N Hart, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Association of Gene Variant Type and Location with Breast Cancer Risk in the General PopulationMwangala P Akamandisa, Nicholas J Boddicker, Siddhartha Yadav, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2021
Risk of Late-Onset Breast Cancer in Genetically Predisposed WomenNicholas J Boddicker, Chunling Hu, Jeffrey N Weitzel, et al.
The New England Journal of Medicine|January 20, 2021
A Population-Based Study of Genes Previously Implicated in Breast CancerChunling Hu, Steven N Hart, Rohan Gnanaolivu, et al.
Scientific Reports|November 16, 2016
rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer riskJingjing Liu, Ivona Lončar, J Margriet Collée, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Analysis of more than 400,000 women provides case-control evidence for <i>BRCA1</i> and <i>BRCA2</i> variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Nature Communications|May 24, 2025
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Journal of Medical Genetics|February 28, 2016
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testingDouglas F Easton, Fabienne Lesueur, Brennan Decker, et al.
The Journal of Pathology|August 23, 2023
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerDavid B Page, Glenn Broeckx, Chowdhury Arif Jahangir, et al.
The Journal of Pathology|January 17, 2024
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast CancerChowdhury Arif Jahangir, David B Page, Glenn Broeckx, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2021
Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk ScoreChi Gao, Eric C Polley, Steven N Hart, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Association of Gene Variant Type and Location with Breast Cancer Risk in the General PopulationMwangala P Akamandisa, Nicholas J Boddicker, Siddhartha Yadav, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2021
Risk of Late-Onset Breast Cancer in Genetically Predisposed WomenNicholas J Boddicker, Chunling Hu, Jeffrey N Weitzel, et al.
The New England Journal of Medicine|January 20, 2021
A Population-Based Study of Genes Previously Implicated in Breast CancerChunling Hu, Steven N Hart, Rohan Gnanaolivu, et al.
Scientific Reports|November 16, 2016
rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer riskJingjing Liu, Ivona Lončar, J Margriet Collée, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Analysis of more than 400,000 women provides case-control evidence for <i>BRCA1</i> and <i>BRCA2</i> variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Nature Communications|May 24, 2025
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Journal of Medical Genetics|February 28, 2016
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testingDouglas F Easton, Fabienne Lesueur, Brennan Decker, et al.
The Journal of Pathology|August 23, 2023
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerDavid B Page, Glenn Broeckx, Chowdhury Arif Jahangir, et al.
The Journal of Pathology|January 17, 2024
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast CancerChowdhury Arif Jahangir, David B Page, Glenn Broeckx, et al.
Pageof 13